FIELD: biotechnology.
SUBSTANCE: present invention relates in particular to the myovirus bacteriophage Esc-COP-4 isolated from nature and having a gene represented by the nucleotide sequence of SEQ ID NO: 1 (registration number: KSTS 12663 BP). Invention also relates to method for preventing or treating infections caused by enteroinvasive E. coli using a composition comprising said bacteriophage as an active ingredient.
EFFECT: inventions allow to use the claimed bacteriophage which is capable of specifically destroying strains of enteroinvasive Escherichia coli and can be used in the medical industry.
5 cl, 2 dwg, 4 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NOVEL BACTERIOPHAGE SHIGA-TOXIN PRODUCING F18 TYPE ESC COP-1 ESCHERICHIA COLI AND APPLICATION THEREOF FOR INHIBITING PROLIFERATION OF SHIGA-TOXIN PRODUCING F18 TYPE ESCHERICHIA COLI | 2015 |
|
RU2662985C1 |
| NOVEL BACTERIOPHAGE CLOSTRIDIUM PERFRINGENS CLO-PEP-1 AND APPLICATION THEREOF FOR INHIBITING PROLIFERATION CLOSTRIDIUM PERFRINGENS | 2015 |
|
RU2662986C1 |
| NEW BACTERIOPHAGE PAS-MUP-1 PASTEURELLA MULTOCIDA AND ITS APPLICATION FOR INHIBITION OF PASTEURELLA MULTOCIDA REPRODUCTION | 2016 |
|
RU2704864C1 |
| NEW BACTERIOPHAGE CLO-PEP-2 CLOSTRIDIUM PERFRINGENS AND ITS APPLICATION FOR INHIBITION OF CLOSTRIDIUM PERFRINGENS PROLIFERATION | 2018 |
|
RU2748805C2 |
| ANTIBACTERIAL COMPOSITION AND METHOD OF TREATING STAPHYLOCOCCUS INFECTIONS WITH ANTIBACTERIAL COMPOSITION | 2017 |
|
RU2729934C2 |
| LYOPHILISED ANTIBACTERIAL PROTEIN COMPOSITIONS | 2017 |
|
RU2734308C2 |
| ANTIBACTERIAL COMPOSITION AND A METHOD OF TREATING STAPHYLOCOCCUS INFECTIONS WITH AN ANTIBACTERIAL COMPOSITION | 2017 |
|
RU2707738C1 |
| LYOPHILISED ANTIBACTERIAL PROTEIN COMPOSITIONS | 2017 |
|
RU2708393C1 |
| ANTIBACTERIAL COMPOSITION, STRAIN OF BACTERIOPHAGE Escherichia coli, USED FOR OBTAINING THEREOF | 2012 |
|
RU2518303C2 |
| ANTIBACTERIAL COMPOSITION (EMBODIMENTS) AND USE OF PROTEIN AS ANTIMICROBIAL AGENT DIRECTED AGAINST BACTERIA PSEUDOMONAS AERUGINOSA, KLEBSIELLA PNEUMONIAE, ESCHERICHIA COLI, SALMONELLA TYPHI AND STAPHYLOCOCCUS HAEMOLYTICUS (EMBODIMENTS) | 2019 |
|
RU2730613C1 |
